Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study.

NCT05923047 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Rhinosinusitis Chronic
Polyp, Nasal

Interventions

DRUG: Mepolizumab
PROCEDURE: Polypeptomy

Sponsor

Instituto de Investigación Marqués de Valdecilla